139 related articles for article (PubMed ID: 23892690)
1. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary.
Dragan AD; Nixon IJ; Guerrero-Urbano MT; Oakley R; Jeannon JP; Simo R
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1249-56. PubMed ID: 23892690
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic selective neck dissection: a 25-year review.
Muzaffar K
Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
6. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
Boscolo-Rizzo P; Gava A; Da Mosto MC
Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
[TBL] [Abstract][Full Text] [Related]
8. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.
Fakhrian K; Thamm R; Knapp S; Molls M; Pigorsch S; Haller B; Geinitz H
Strahlenther Onkol; 2012 Jan; 188(1):56-61. PubMed ID: 22189437
[TBL] [Abstract][Full Text] [Related]
9. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome.
Wang JT; Palme CE; Wang AY; Morgan GJ; Gebski V; Veness MJ
J Laryngol Otol; 2013 Jan; 127 Suppl 1():S2-7. PubMed ID: 23046820
[TBL] [Abstract][Full Text] [Related]
10. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
[TBL] [Abstract][Full Text] [Related]
11. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
[TBL] [Abstract][Full Text] [Related]
12. The effects of more conservative neck dissections and radiotherapy on nodal yields from the neck.
Bhattacharyya N
Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):412-6. PubMed ID: 9559688
[TBL] [Abstract][Full Text] [Related]
13. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.
Elicin O; Albrecht T; Haynes AG; Bojaxhiu B; Nisa L; Caversaccio M; Dal Pra A; Schmücking M; Aebersold DM; Giger R
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):300-8. PubMed ID: 26450749
[TBL] [Abstract][Full Text] [Related]
15. When to manage level V in head and neck carcinoma?
Naiboğlu B; Karapinar U; Agrawal A; Schuller DE; Ozer E
Laryngoscope; 2011 Mar; 121(3):545-7. PubMed ID: 21344432
[TBL] [Abstract][Full Text] [Related]
16. Cervical nodal metastases from occult primary: undifferentiated carcinoma versus squamous cell carcinoma.
Tong CC; Luk MY; Chow SM; Ngan KC; Lau WH
Head Neck; 2002 Apr; 24(4):361-9. PubMed ID: 11933178
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
Lim YC; Lee JS; Choi EC
Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
[TBL] [Abstract][Full Text] [Related]
19. [Post-therapeutic imaging strategies and follow-up in head and neck malignant tumours].
Aschenbach R; Esser D
HNO; 2010 Aug; 58(8):749-55. PubMed ID: 20640391
[TBL] [Abstract][Full Text] [Related]
20. Elective neck dissection in oral carcinoma: a critical review of the evidence.
Kowalski LP; Sanabria A
Acta Otorhinolaryngol Ital; 2007 Jun; 27(3):113-7. PubMed ID: 17883186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
